As the primary industrial route for beryllium (Be) production, the magnesiothermic reduction of BeF 2 generates toxic, Be-laden reduction slag, posing severe ecological risks and wasting critical strategic resources. To overcome the prohibitive costs and incomplete recovery of conventional remediation, a phase-tailored hydrometallurgy is proposed. The phase-specific distribution and physical occurrence of Be are unveiled through systematic multi-scale characterization. Initial aqueous leaching quantitatively establishes that 25.6% of the Be in the slag is present as highly soluble BeF 2 , whose selective dissolution thereby facilitates the deep extraction of residual Be via targeted HF leaching. Crucially, the requisite HF concentration is reduced from 18 wt.% to 8 wt.%, and processing duration is condensed from 6 h to 10 min. This parametric optimization yields a 99.1% extraction efficiency while significantly mitigating equipment corrosion and energy consumption. Concurrently, upon further processing, the depleted residue (retaining merely 0.029 wt.% Be) can be valorized as important chemical products. Furthermore, the leachates yield a refined BeF 2 product with 99.8% purity, achieving a 99.3% cumulative recovery. This process offers a highly sustainable strategy for comprehensive Be valorization, contributing to the mitigation of ecological hazards and the loss of critical resources.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: